XFOR - X4 Pharmaceuticals Inc
4.15
0.390 9.398%
Share volume: 590,387
Last Updated: 03-09-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.00%
PREVIOUS CLOSE
CHG
CHG%
$3.76
0.39
0.10%
Summary score
9%
Profitability
8%
Dept financing
11%
Liquidity
50%
Performance
0%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-26.46%
Return on assets
-18.72%
Return on sales
0%
Return on invested capital
42.62%
Total debt ratio
55.14%
Debt ratio change over timeo
0%
Current Ratio
6.92%
Quick Ratio
0%
Cash Position Ratio
6.6%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-13.65%
Return on assets
-8.96%
Return on sales
0%
Return on invested capital
-61.43%
Total debt ratio
24.13%
Debt ratio change over timeo
0%
Current Ratio
12.2%
Quick Ratio
0%
Cash Position Ratio
11.67%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-14.44%
Return on assets
-10.28%
Return on sales
0%
Return on invested capital
-69.26%
Total debt ratio
26.41%
Debt ratio change over time
0%
Current Ratio
10.19%
Quick Ratio
0%
Cash Position Ratio
9.62%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | XFOR | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -26.46% | 11.55% | 5.76% | 8.53% |
| Return on assets | -18.72% | 3.57% | 4.02% | 5.96% |
| Return on sales | 0% | 42.16% | 39.53% | 45.73% |
| Return on invested capital | 42.62% | 7.99% | 5.61% | 8.26% |
| Profitability | 25% | 68% | 54% | 73% |
| Total debt ratio | 55.14% | 74.11% | 65.71% | 48.2% |
| Debt ratio change over time | 0% | 0% | 376.49% | 4.51% |
| Dept financing | 19% | 25% | 47% | 17% |
| Current Ratio | 12.2% | 2.02% | 2.86% | 1.95% |
| Quick Ratio | 0% | 1.71% | 2.76% | 1.76% |
| Cash Position Ratio | 11.67% | 0.76% | 2.25% | 1% |
| Liquididy | 50% | 40% | 40% | 28% |
| Short-term ratios | XFOR | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -13.65% | 17.94% | -1.29% | 11.66% |
| Return on assets | -8.96% | 3.67% | 1.51% | 6.9% |
| Return on sales | 0% | 37.5% | 16.39% | 50.72% |
| Return on invested capital | -61.43% | 7.17% | -0.65% | 10.66% |
| Profitability | 0% | 74% | 14% | 91% |
| Total debt ratio | 24.13% | 83.42% | 64.86% | 51.93% |
| Debt ratio change over time | 0% | 0% | 1.76% | 4.05% |
| Dept financing | 7% | 25% | 30% | 41% |
| Current Ratio | 12.2% | 2.02% | 2.86% | 1.95% |
| Quick Ratio | 0% | 1.71% | 2.76% | 1.76% |
| Cash Position Ratio | 11.67% | 0.76% | 2.25% | 1% |
| Liquididy | 50% | 21% | 36% | 22% |